FSA Requests Evidence for Determining Safe Ashwagandha Levels for Its Use in Food Supplements

Wto Publishes A Draft Ukrainian Regulation On The Production And Circulation Of Dietary Supplements

The UK Food Standards Agency (FSA) has issued a call for evidence regarding ashwagandha food supplements. This initiative aims to gather information to support a risk assessment by the Committee on Toxicity, seeking to establish a safe level of ashwagandha for use in food supplements while assessing potential health risks. Ashwagandha, also known as Withania somnifera, is popular for its purported health benefits, including stress relief and improved focus. However, concerns have been raised about its effects on thyroid hormone levels, potential liver toxicity, and hypoglycemic effects. The call for evidence is open until September 2, 2024, and is relevant for food business operators (FBOs) and other stakeholders involved in the manufacture, distribution, or sale of ashwagandha-containing supplements.

For more details, ask RegAsk

©This RegAlert is issued by RegASK

What you'll get with RegASK

  • Early detection and mitigation of regulatory risks 
  • End-to-end regulatory support throughout your product lifecycle
  • Strategic consulting to build the optimal business strategy for your commercial success

Book a demo

Have a
regulatory affairs
challenge?

Regulatory Affair Icon